Inflammation Induces TDP-43 Mislocalization and Aggregation
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
TAR DNA-binding protein 43 (TDP-43) is a major component in aggregates of ubiquitinated proteins in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Here we report that lipopolysaccharide (LPS)-induced inflammation can promote TDP-43 mislocalization and aggregation. In culture, microglia and astrocytes exhibited TDP-43 mislocalization after exposure to LPS. Likewise, treatment of the motoneuron-like NSC-34 cells with TNF-alpha (TNF-α) increased the cytoplasmic levels of TDP-43. In addition, the chronic intraperitoneal injection of LPS at a dose of 1mg/kg in TDP-43(A315T) transgenic mice exacerbated the pathological TDP-43 accumulation in the cytoplasm of spinal motor neurons and it enhanced the levels of TDP-43 aggregation. These results suggest that inflammation may contribute to development or exacerbation of TDP-43 proteinopathies in neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, peripheral LPS promotes TDP-43 mislocalization and aggregation, contributing to TDP-43 proteinopathies in neurodegenerative disorders, such as FTLD and ALS.243”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [243]
In the citing paper
“endotoxin promotes TDP-43 aggregation and neuropathology.”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [103]
In the citing paper
“Addition of LPS to microglia or astrocytes in culture resulted in TDP-43 mislocalization and aggregation, and addition of peripheral LPS to TDP-43(A315T) transgenic mice resulted in TDP-43 aggregation in vivo [103].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [103]
In the citing paper
“This suggests a dual-hit hypothesis for ALS and FTD: increased endotoxin levels plus aggregable TDP-43 results in neurodegeneration.”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [103]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576 · cited 8×
“In summary, the in vitro and in vivo results presented here suggest that inflammation, induced by stimuli of NF-κB signaling such as TNF-α or LPS, may be a mediator of TDP-43 proteinopathy which constitutes a pathological hallmark of ALS and FTLD [4–9].”
BackgroundMethodResultInfluentialArai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
Kabashi, E., Valdmanis, P. N., Dion, P., Spiegelman, D., McConkey, B. J., Velde, C. V., Bouchard, J.-P., Lacomblez, L., Pochigaeva, K., Salachas, F., et al. (2008) · Nature Genetics · doi:10.1038/ng.132 · Cited by 1,544
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Vande Velde, C., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,429
Mackenzie, I. R. A., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., Cairns, N. J., Kwong, L. K., Forman, M. S., Ravits, J., Stewart, H., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21147 · Cited by 992 · cited 1×
“We carried out the immunoblots with a widely used polyclonal antibody against TDP-43 [4,5, 8, 6,7, 29, 23], which reacts with both mouse and human TDP-43 species and yields a band at 43 kDa corresponding to the unmodified TDP-43.”
MethodTDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia
Mackenzie, I. R., Rademakers, R., & Neumann, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70195-2 · Cited by 975
Van Deerlin, V. M., Leverenz, J. B., Bekris, L. M., Bird, T. D., Yuan, W., Elman, L. B., Clay, D., Wood, E. M., Chen-Plotkin, A. S., Martinez-Lage, M., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70071-1 · Cited by 723
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M., & Baloh, R. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908767106 · Cited by 706
Innate immunity: the missing link in neuroprotection and neurodegeneration?
Nguyen, M. D., Julien, J.-P., & Rivest, S. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn752 · Cited by 701
Self-citation
Cited by
Lipopolysaccharide-induced neuroinflammation as a bridge to understand neurodegeneration
Batista, C. R. A., Gomes, G. F., Candelario-Jalil, E., Fiebich, B. L., & de Oliveira, A. C. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092293 · Cited by 529
“TAR DNA-binding protein (TDP-43), a major component of cytoplasmic inclusions in sporadic and most familial ALS cases, appeared accumulated and aggregated in the cytoplasm of spinal motor neurons of TDP-43A315T transgenic mice after chronic LPS administration [145].”
BackgroundThe endotoxin hypothesis of neurodegeneration
Brown, G. C. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1564-7 · Cited by 457
Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies
Beers, D. R., & Appel, S. H. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30394-6 · Cited by 388
Inclusion body myositis: clinical features and pathogenesis
Greenberg, S. A. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0186-x · Cited by 273
The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
Rey, N. L., Wesson, D. W., & Brundin, P. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.013 · Cited by 257
“, 2013), inflammation can in return promote the aggregation of some prion-like proteins in the brain and peripheral cells (Correia et al., 2015; He et al., 2013; Kitazawa et al., 2005; Lee et al., 2008; Sy et al., 2011; Vieira et al., 2015).”
Kearns, R. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01496-z · Cited by 193
Kamma, E., Lasisi, W., Libner, C., Ng, H. S., & Plemel, J. R. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02408-y · Cited by 143
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
TDP-43/FUS in motor neuron disease: Complexity and challenges
Guerrero, E. N., Wang, H., Mitra, J., Hegde, P. M., Stowell, S. E., Liachko, N. F., Kraemer, B. C., Garruto, R. M., Rao, K. S., & Hegde, M. L. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.09.004 · Cited by 140
Béland, L.-C., Markovinovic, A., Jakovac, H., De Marchi, F., Bilic, E., Mazzini, L., Kriz, J., & Munitic, I. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa124 · Cited by 125
“settings, nuclear TDP-43 gets phosphorylated, mislocalized and aggregated in the cytoplasm (Correia et al., 2015; Xue et al., 2018b).”
BackgroundQuek, H., Cuní‐López, C., Stewart, R., Colletti, T., Notaro, A., Sun, Y., Guo, C. C., Lupton, M. K., Nguyen, T. H., Oikari, L. E., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02421-1 · Cited by 122
Non‐neuronal Cells in ALS: Role of Glial, Immune cells and Blood‐CNS Barriers
Puentes, F., Malaspina, A., van Noort, J. M., & Amor, S. (2016) · Brain Pathology · doi:10.1111/bpa.12352 · Cited by 98
Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology
Lyon, M. S., Wosiski‐Kuhn, M., Gillespie, R., Caress, J., & Milligan, C. (2019) · Muscle & Nerve · doi:10.1002/mus.26289 · Cited by 87
Markovinović, A., Cimbro, R., Ljutić, T., Križ, J., Rogelj, B., & Munitić, I. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.04.005 · Cited by 101
Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis
Pehar, M., Harlan, B. A., Killoy, K. M., & Vargas, M. R. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612823666170622095802 · Cited by 78
Zamudio, F., Loon, A. R., Smeltzer, S., Benyamine, K., Navalpur Shanmugam, N. K., Stewart, N. J. F., Lee, D. C., Nash, K., & Selenica, M.-L. B. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01952-9 · Cited by 74
TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Bright, F., Chan, G., van Hummel, A., Ittner, L. M., & Ke, Y. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157781 · Cited by 71
Steinruecke, M., Lonergan, R. M., Selvaraj, B. T., Chandran, S., Castro, B. D., & Stavrou, M. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231153281 · Cited by 67
Stress induced TDP-43 mobility loss independent of stress granules
Streit, L. M., Kuhn, T., Vomhof, T., Bopp, V., Ludolph, A. C., Weishaupt, J. H., Gebhardt, J. C. M., Michaelis, J., & Danzer, K. M. (2022) · Nature Communications · doi:10.1038/s41467-022-32939-0 · Cited by 66
Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia
Malpetti, M., Cope, T., Street, D., Jones, P. S., Hezemans, F. H., Mak, E., Tsvetanov, K. A., Rittman, T., Bevan-Jones, W. R., Patterson, K. E., et al. (2023) · Brain · doi:10.1093/brain/awad078 · Cited by 66
The Links between ALS and NF-κB
Källstig, E., McCabe, B. D., & Schneider, B. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083875 · Cited by 65
Thammisetty, S. S., Pedragosa, J., Weng, Y. C., Calon, F., Planas, A., & Kriz, J. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1350-y · Cited by 59
Leal‐Lasarte, M. M., Franco, J. M., Labrador‐Garrido, A., Pozo, D., & Roodveldt, C. (2017) · The FASEB Journal · doi:10.1096/fj.201601163r · Cited by 53
Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy
Cagnin, A., Mariotto, S., Fiorini, M., Gaule, M., Bonetto, N., Tagliapietra, M., Buratti, E., Zanusso, G., Ferrari, S., & Monaco, S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170189 · Cited by 59
Pasetto, L., Pozzi, S., Castelnovo, M., Basso, M., Estevez, A. G., Fumagalli, S., De Simoni, M. G., Castellaneta, V., Bigini, P., Restelli, E., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2462-16.2016 · Cited by 52
Dutta, K., Patel, P., Rahimian, R., Phaneuf, D., & Julien, J.-P. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0499-2 · Cited by 51
Self-citationKuntić, M., Hahad, O., Münzel, T. F., & Daiber, A. (2024) · Antioxidants · doi:10.3390/antiox13030266 · Cited by 56
Reversible induction of TDP-43 granules in cortical neurons after traumatic injury
Wiesner, D., Tar, L., Linkus, B., Chandrasekar, A., Heuvel, F. O., Dupuis, L., Tsao, W., Wong, P. C., Ludolph, A. C., & Roselli, F. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.09.011 · Cited by 50
Glial TDP‐43 and TDP‐43 induced glial pathology, focus on neurodegenerative proteinopathy syndromes
Prater, K. E., Latimer, C. S., & Jayadev, S. (2021) · Glia · doi:10.1002/glia.24096 · Cited by 51
Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration
Kellett, E. A., Bademosi, A. T., & Walker, A. K. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00839-8 · Cited by 49
TDP-43: A Key Therapeutic Target beyond Amyotrophic Lateral Sclerosis
Palomo, V., Tosat‐Bitrián, C., Nozal, V., Nagaraj, S., Martín‐Requero, Á., & Martínez, A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00026 · Cited by 48
Pathophysiology of stress granules: An emerging link to diseases (Review)
Wang, J., Gan, Y., Cao, J. P., Dong, X.-F., & Ouyang, W. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5099 · Cited by 47
Transmission of ALS pathogenesis by the cerebrospinal fluid
Mishra, P. S., Boutej, H., Soucy, G., Bareil, C., Kumar, S., Picher‐Martel, V., Dupré, N., Križ, J., & Julien, J. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00943-4 · Cited by 45
Self-citationMukherjee, M., & Goswami, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237559 · Cited by 45
The Molecular Clock and Neurodegenerative Disease: A Stressful Time
Carter, B., Justin, H. S., Gulick, D., & Gamsby, J. J. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.644747 · Cited by 42
Gut microbiota immune cross-talk in amyotrophic lateral sclerosis
Kaul, M., Mukherjee, D., Weiner, H. L., & Cox, L. M. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00469 · Cited by 42
Neuroinflammation and Neurodegeneration
Morales, I., Farias, G. A., Cortés, N., & Maccioni, R. B. (2016) · InTech eBooks · doi:10.5772/64545 · Cited by 41
Neuronal RNA‐binding protein dysfunction in multiple sclerosis cortex
Salapa, H. E., Hutchinson, C., Popescu, B. F. G., & Levin, M. C. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51103 · Cited by 40
Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis
Richardson, P. J., Smith, D. P., de Giorgio, A., Snetkov, X., Almond-Thynne, J., Cronin, S., Mead, R. J., McDermott, C. J., & Shaw, P. J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00380-y · Cited by 40
Hong, D., Zhang, C., Wu, W., Lu, X., & Zhang, L. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1133546 · Cited by 38
Sung, W., Noh, M., Nahm, M., Kim, Y. S., Ki, C., Kim, Y.-E., Kim, H.-J., & Kim, S. H. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03039-1 · Cited by 37
Addition of exogenous SOD1 aggregates causes TDP-43 mislocalisation and aggregation
Zeineddine, R., Farrawell, N. E., Lambert-Smith, I. A., & Yerbury, J. J. (2017) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0804-y · Cited by 34
The role of immune-mediated alterations and disorders in ALS disease
Rodrigues Lima-Junior, J., Sulzer, D., Lindestam Arlehamn, C. S., & Sette, A. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.01.017 · Cited by 33
Jeon, P., Ham, H.-J., Park, S., & Lee, J. (2022) · Cells · doi:10.3390/cells11132063 · Cited by 33
TDP-43 proteinopathy in Theiler’s murine encephalomyelitis virus infection
Masaki, K., Sonobe, Y., Ghadge, G. D., Pytel, P., & Roos, R. P. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007574 · Cited by 33
Salapa, H. E., Libner, C. D., & Levin, M. C. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24554 · Cited by 33
RNA-binding protein altered expression and mislocalization in MS
Masaki, K., Sonobe, Y., Ghadge, G. D., Pytel, P., Lépine, P., Pernin, F., Cui, Q., Antel, J. P., Zandee, S., Prat, A., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000704 · Cited by 32
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
Marchi, F. D., Franjkic, T., Schito, P., Russo, T., Nimac, J., Chami, A. A., Mele, A., Vidatic, L., Križ, J., Julien, J., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061599 · Cited by 31
Self-citationReviewing the Potential Links between Viral Infections and TDP-43 Proteinopathies
Rahic, Z., Buratti, E., & Cappelli, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021581 · Cited by 30
Ho, P., Hsieh, T., & Tsai, K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102441 · Cited by 29
Ahnaou, A., & Drinkenburg, W. H. I. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.039 · Cited by 26
Mitra, J., Kodavati, M. M., Dharmalingam, P., Guerrero, E. N., Rao, K. S. J., Garruto, R. M., & Hegde, M. L. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-01962-9 · Cited by 25
Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease
Nelson, A. R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.858429 · Cited by 25
Environmental Subconcussive Injury, Axonal Injury, and Chronic Traumatic Encephalopathy
Morley, W. A. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00166 · Cited by 24
Libner, C. D., Salapa, H. E., & Levin, M. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134571 · Cited by 24
Charge and redox states modulate granulin—TDP-43 coacervation toward phase separation or aggregation
Bhopatkar, A. A., Dhakal, S., Abernathy, H. G., Morgan, S. E., & Rangachari, V. (2022) · Biophysical Journal · doi:10.1016/j.bpj.2022.04.034 · Cited by 24
Glia in amyotrophic lateral sclerosis and spinal cord injury: common therapeutic targets
Ban, J., Sámano, C., Mladinić, M., & Munitić, I. (2019) · Croatian Medical Journal · doi:10.3325/cmj.2019.60.109 · Cited by 23
A Docosahexaenoic Acid-Derived Pro-resolving Agent, Maresin 1, Protects Motor Neuron Cells Death
Ohuchi, K., Ono, Y., Joho, M., Tsuruma, K., Ogami, S., Yamane, S., Funato, M., Kaneko, H., Nakamura, S., Hara, H., et al. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2556-1 · Cited by 22
Kım, G., Bolbolan, K., Gefen, T. D., Weıntraub, S., Bigio, E. H., Rogalski, E. J., Mesulam, M. M., & Geula, C. (2018) · Annals of Neurology · doi:10.1002/ana.25240 · Cited by 22
A Commentary on TDP-43 and DNA Damage Response in Amyotrophic Lateral Sclerosis
Mitra, J., & Hegde, M. L. (2019) · Journal of Experimental Neuroscience · doi:10.1177/1179069519880166 · Cited by 21
Dysfunction of RNA/RNA-Binding Proteins in ALS Astrocytes and Microglia
Rossi, S., & Cozzolino, M. (2021) · Cells · doi:10.3390/cells10113005 · Cited by 20
Zhang, J., Xie, D., Jiao, D., Zhou, S. Y., Liu, S., Ju, Z., Hu, L., Li, Q., Yao, C., & Chen, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32688 · Cited by 19
Banik, A., Amaradhi, R., Lee, D. D., Sau, M., Wang, W., Dingledine, R. J., & Ganesh, T. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02297-7 · Cited by 19
Little Helpers or Mean Rogue—Role of Microglia in Animal Models of Amyotrophic Lateral Sclerosis
Cihankaya, H., Theiß, C., & Matschke, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22030993 · Cited by 19
Energy Homeostasis and Abnormal RNA Metabolism in Amyotrophic Lateral Sclerosis
Liu, Y., Tsai, P.-Y., & Chern, Y. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00126 · Cited by 19
The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration
Öztürk, M. M., Emgård, J., García‐Revilla, J., Fernández‐Calle, R., Yang, Y., Deierborg, T., & Roos, T. T. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf087 · Cited by 17
Santiago, J., Pocevičiūtė, D., Bank, T. N. B., & Wennström, M. (2024) · Brain Pathology · doi:10.1111/bpa.13304 · Cited by 16
Cheataini, F., Ballout, N., & Sagheer, T. A. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25198 · Cited by 15
Autoimmunity to a ribonucleoprotein drives neuron loss in multiple sclerosis models
Libner, C. D., Salapa, H. E., Hutchinson, C., Stang, T. E., Thibault, P. A., Hammond, S. A., & Levin, M. C. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105775 · Cited by 14
hnRNP A1 dysfunction in oligodendrocytes contributes to the pathogenesis of multiple sclerosis
Jahan‐Abad, A. J., Salapa, H. E., Libner, C. D., Thibault, P. A., & Levin, M. C. (2022) · Glia · doi:10.1002/glia.24300 · Cited by 14
Do Sleep Disturbances have a Dual Effect on Alzheimer’s Disease?
Arjmandi-Rad, S., Ebrahimnejad, M., Zarrindast, M., & Vaseghi, S. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01228-1 · Cited by 13
Optineurin Deficiency and Insufficiency Lead to Higher Microglial TDP-43 Protein Levels
Prtenjača, N., Rob, M., Alam, M. S., Markovinović, A., Stuani, C., Buratti, E., & Munitić, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126829 · Cited by 13
Janković, T., & Pilipović, K. (2023) · Experimental Neurobiology · doi:10.5607/en23008 · Cited by 13
He, T., Zuo, Y., Ai‐Zakwani, K., Luo, J., Zhu, H., Yan, X., & Liu, F. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6636 · Cited by 12
Does Glyphosate Acting as a Glycine Analogue Contribute To ALS?
Seneff, S. (2016) · JOURNAL OF BIOINFORMATICS AND PROTEOMICS REVIEW · doi:10.15436/2381-0793.16.1173 · Cited by 11
Li, M., Hamilton, R., Salapa, H. E., & Levin, M. C. (2021) · Brain Sciences · doi:10.3390/brainsci11101282 · Cited by 11
Janković, T., Dolenec, P., Bumber, J. R., Gržeta, N., Križ, J., Župan, G., & Pilipović, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212211 · Cited by 11
Elevated TDP-43 serum levels associated with postoperative delirium following major cardiac surgery
Simon, C., Graves, O. K., Akeju, O., & McKay, T. B. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.100974 · Cited by 10
Melnick, M., Gonzales, P. K., LaRocca, T. J., Song, Y., Wuu, J., Benatar, M. G., Oskarsson, B., Petrucelli, L., Dowell, R. D., Link, C. D., et al. (2021) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkab141 · Cited by 10
Zhou, D., Yan, H., Yang, S., Zhang, Y., Xu, X., Cen, X., Lei, K., & Xia, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.741219 · Cited by 8
Wu, Q., Yang, J., Duan, Y., Ma, Y., Zhang, Y., Tan, S., Wang, J., Wang, Y., Liu, B., Zhang, J., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1541779 · Cited by 7
TDP-43–immunity–microbiota axis in amyotrophic lateral sclerosis: A potential pathogenic mechanism
Abbassi, Y., Fink, D., Cei, F., Niccolai, E., & Amedei, A. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00440 · Cited by 5
Non-cell autonomous autophagy in amyotrophic lateral sclerosis: A new promising target?
Rosso, F., Magdalena, R., Torazza, C., Bacchetti, F., Milanese, M., Poletti, A., Bonanno, G., Cristofani, R., & Bonifacino, T. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107203 · Cited by 5
Zebrafish TDP43 positively regulates p65-mediated apoptotic pathway
Yu, T., Li, M., Li, M., Zhang, Q., Zhang, H., Jiang, Z., Wang, S., Mao, H., Li, D., Fan, L., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142599 · Cited by 5
Contribution of neuroinflammation, resolution, and neuroprotection in neurodegenerative diseases
Farooqui, A. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-88460-0.00010-2 · Cited by 5
Neuropathologic changes at age 90+ related to sleep duration 19 to 40 years earlier: The 90+ Study
Melikyan, Z. A., Kawas, C. H., Paganini‐Hill, A., Jiang, L., Bukhari, S. A., Montine, T. J., Mander, B. A., & Corrada, M. M. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13798 · Cited by 5
CHCHD10P80L knock-in zebrafish display a mild ALS-like phenotype
Légaré, V. P., Harji, Z. A., Rampal, C. J., Antonická, H., Gurberg, T. J. N., Persia, O., Rodríguez, E. C., Shoubridge, E. A., & Armstrong, G. A. B. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114945 · Cited by 5
CSF pTDP-43 across the Alzheimer's spectrum: Links to amyloid, APOE and vasculopathy
Rafiee, Z., Pocevičiūtė, D., Santiago, J., Mahmoud, R., Janelidze, S., Hansson, O., & Wennström, M. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107193 · Cited by 4
Umahara, T., Uchihara, T., Hirao, K., Shimizu, S., Hashimoto, T., Akimoto, J., Kohno, M., & Hanyu, H. (2020) · PubMed · doi:10.14670/hh-18-140 · Cited by 4
Mitra, J., Dharmalingam, P., Kodavati, M. M., Guerrero, E. N., Rao, K. S. J., & Hegde, M. L. (2024) · Research Square · doi:10.21203/rs.3.rs-3879966/v1 · Cited by 4
Hu, Y., Chourpiliadis, C. P., Ingre, C., Ahlqvist, V. H., Sun, J., Song, H., Pawitan, Y., Piehl, F., & Fang, F. (2025) · Journal of Internal Medicine · doi:10.1111/joim.70008 · Cited by 3
Shao, J., Su, T., Wang, J., Yin, X., Lang, Y., Fu, Y., & Cui, L. (2025) · AMB Express · doi:10.1186/s13568-025-01932-3 · Cited by 3
Contribution of neuroinflammation, resolution, and neuroprotection in neuropsychiatric diseases
Farooqui, A. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-88460-0.00002-3 · Cited by 3
Current biomarkers in inclusion body myositis
Daniel, E., Smith, I. C. P., Sampaio, M. L., Melkus, G., Hamilton, L. E., Bourque, P. R., & Warman‐Chardon, J. (2024) · Journal of Neuromuscular Diseases · doi:10.1177/22143602241286712 · Cited by 3
Targeting Macrophage for the Treatment of Amyotrophic Lateral Sclerosis
Li, L., Liu, J., & She, H. (2019) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527318666190409103831 · Cited by 3
Neuroinflammation in Age-Related Neurodegenerative Diseases
MacPherson, K. P., Rodrigues, M. E. D. S., Cintron, A. F., & Tansey, M. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00016-x · Cited by 3
The Role of TDP-43 in Genome Repair and beyond in Amyotrophic Lateral Sclerosis
Mitra, J., & Hegde, M. L. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92696 · Cited by 3
Mitra, J., Dharmalingam, P., Kodavati, M. M., Guerrero, E. N., Rao, K. S. J., Garruto, R. M., & Hegde, M. L. (2024) · Research Square · doi:10.21203/rs.3.rs-3879966/v2 · Cited by 3
Antibody targeting TDP-43 mitigates pathogenic pathways induced by the cerebrospinal fluid of ALS
Poulin-Brière, A., Pozzi, S., & Julien, J. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00737 · Cited by 2
Self-citationFarooqui, A. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821039-0.00004-6 · Cited by 2
Metadata
- Authors
- Correia, A. S., Patel, P., Dutta, K., & Julien, J.-P.
- Affiliations
- Centre hospitalier universitaire de Québec (CA)
- Institut Universitaire en Santé Mentale de Québec (CA)
- Corresponding author
- Julien, Jean-Pierre
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-10-07
- Volume
- 10
- Issue
- 10
- Pages
- e0140248
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4596857
- OpenAlex
- W1621668151
- Cited by
- 114
- References
- 39
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 14 · 2023: 9 · 2022: 12 · 2021: 17 · 2020: 10 · 2019: 11 · 2018: 9 · 2017: 6 · 2016: 6
- FWCI
- 4.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- TDP-43, protein aggregation, mislocalization, neuroinflammation, lipopolysaccharide, microglia, astrocytes, TNF-α, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, motor neurons, neurodegeneration
- MeSH terms
- Animals, Astrocytes, Cells, Cultured, DNA-Binding Proteins, Gene Expression Regulation, Humans, Inflammation, Lipopolysaccharides, Mice, Transgenic, RNA, Messenger, Point Mutation, Microglia, Mice, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.